Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2007

01-07-2007 | Original Article

Adherence to Antiretroviral Therapy Assessed by Unannounced Pill Counts Conducted by Telephone

Authors: Seth C. Kalichman, PhD, Christina M. Amaral, BA, Heidi Stearns, BA, Denise White, BA, Jody Flanagan, BA, Howard Pope, BS, Chauncey Cherry, MPH, Demetria Cain, MPH, Lisa Eaton, BA, Moira O. Kalichman, MSW

Published in: Journal of General Internal Medicine | Issue 7/2007

Login to get access

Abstract

BACKGROUND

Unannounced pill counts conducted in patients’ homes is a valid objective method for monitoring medication adherence that is unfortunately costly and often impractical. Conducting unannounced pill counts by telephone may be a viable alternative for objectively assessing medication adherence.

PURPOSE

To test an unannounced pill count assessment of adherence conducted by telephone.

METHODS

HIV-positive men and women (N = 77) in Atlanta GA completed an unannounced telephone-based pill count immediately followed by a pill count conducted in an unannounced home visit.

RESULTS

A high degree of concordance was observed between phone and home-based number of pills counted (Intraclass correlation, ICC = .997, 95% CI .995–.998, P < .001) and percent of pills taken (ICC = .990, 95% CI .986–.992, P < .001). Concordance between adherence above/below 90% and phone/home counts was 95%, Kappa coefficient = .995. Concordance between pill counts was not influenced by participant education or health literacy and was maintained when the data were censored to remove higher levels of adherence. Analyses of discordant pill counts found the most common source of error resulted from overcounted doses in pillboxes on the telephone.

CONCLUSIONS

Unannounced phone-based pill counts offer an economically and logistically feasible objective method for monitoring medication adherence.
Literature
1.
go back to reference Bangsberg DR, Acosta EP, Gupta R, Guzman D, Riley ED, Harrigan PR, Parkin N, Deeks R. Adherence-resistence relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20:223–231.PubMedCrossRef Bangsberg DR, Acosta EP, Gupta R, Guzman D, Riley ED, Harrigan PR, Parkin N, Deeks R. Adherence-resistence relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20:223–231.PubMedCrossRef
2.
go back to reference Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMed Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMed
3.
go back to reference Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Provider assessment of adherence to HIV antiretroviral therapy. J AIDS. 2001a;26:435–442. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Provider assessment of adherence to HIV antiretroviral therapy. J AIDS. 2001a;26:435–442.
4.
go back to reference Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42:649–652.PubMed Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42:649–652.PubMed
5.
go back to reference Simoni J, Kurth AE, Pearson C, Pantalone DW, Merrill J, Frick P. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–331.PubMed Simoni J, Kurth AE, Pearson C, Pantalone DW, Merrill J, Frick P. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–331.PubMed
6.
go back to reference Wagner G, Miller LG. Is the influence of social desirability on patient’s self-reported adherence overrated? J AIDS. 2004;36:203–204. Wagner G, Miller LG. Is the influence of social desirability on patient’s self-reported adherence overrated? J AIDS. 2004;36:203–204.
7.
go back to reference Wendel CS, Mohler JM, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35:1010–1015.PubMed Wendel CS, Mohler JM, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35:1010–1015.PubMed
8.
go back to reference Kalichman DC, Cain D, Cherry C, Kalichman M, Pope H. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDs. 2005;19:49–55. Kalichman DC, Cain D, Cherry C, Kalichman M, Pope H. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDs. 2005;19:49–55.
9.
go back to reference Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57:1007–1110. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57:1007–1110.
10.
go back to reference Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32:749–754.PubMed Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32:749–754.PubMed
11.
go back to reference Liechty C, Alexander C, Harrigan R, Guzman D, Charlebois E, Moss A, Bangsberg D. Are untimed antiretroviral drug levels useful predictors of adherence behavior? AIDS. 2004;18:121–129. Liechty C, Alexander C, Harrigan R, Guzman D, Charlebois E, Moss A, Bangsberg D. Are untimed antiretroviral drug levels useful predictors of adherence behavior? AIDS. 2004;18:121–129.
12.
go back to reference Rabkin JG, Chesney M. Treatment adherence to HIV medications: the Achilles heel of the new therapeutics. In: Ostrow D, Kalichman S, eds. Behavioral and Mental Health Impacts of New HIV Therapies. New York: Plenum Press; 1999. Rabkin JG, Chesney M. Treatment adherence to HIV medications: the Achilles heel of the new therapeutics. In: Ostrow D, Kalichman S, eds. Behavioral and Mental Health Impacts of New HIV Therapies. New York: Plenum Press; 1999.
13.
go back to reference Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275–281. Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275–281.
14.
go back to reference Bangsberg DR, Hecht FM, Charlebois ED, Zopola AR, Holodniy M, Sheiner L, Bamberger JD, Chesney M, Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–366.PubMed Bangsberg DR, Hecht FM, Charlebois ED, Zopola AR, Holodniy M, Sheiner L, Bamberger JD, Chesney M, Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–366.PubMed
15.
go back to reference Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg D. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74–79.PubMed Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg D. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74–79.PubMed
16.
go back to reference Oyugi JH, Byakika-Tuslime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg D. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J AIDS. 2004;36:1100–1102. Oyugi JH, Byakika-Tuslime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg D. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J AIDS. 2004;36:1100–1102.
17.
go back to reference Parker RM, Baker DW, Williams MV, Nurss JR. The test of functional health literacy in adults: a new instrument for measuring patients’ literacy skills. J Gen Intern Med. 1995;10:537–541.PubMed Parker RM, Baker DW, Williams MV, Nurss JR. The test of functional health literacy in adults: a new instrument for measuring patients’ literacy skills. J Gen Intern Med. 1995;10:537–541.PubMed
Metadata
Title
Adherence to Antiretroviral Therapy Assessed by Unannounced Pill Counts Conducted by Telephone
Authors
Seth C. Kalichman, PhD
Christina M. Amaral, BA
Heidi Stearns, BA
Denise White, BA
Jody Flanagan, BA
Howard Pope, BS
Chauncey Cherry, MPH
Demetria Cain, MPH
Lisa Eaton, BA
Moira O. Kalichman, MSW
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0171-y

Other articles of this Issue 7/2007

Journal of General Internal Medicine 7/2007 Go to the issue